Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2026-01-29 @ 12:55 AM
Study NCT ID:
NCT01808950
Status:
TERMINATED
Last Update Posted:
2016-06-22
First Post:
2013-03-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Trial of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma
Sponsor:
Spirig Pharma Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02
Start Date Type:
None
Primary Completion Date:
2013-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-03-05
First Submit QC Date:
None
Study First Post Date:
2013-03-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-12-03
Results First Submit QC Date:
None
Results First Post Date:
2016-06-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-05-12
Last Update Post Date:
2016-06-22
Last Update Post Date Type:
ESTIMATED